Create issue ticket

396 Possible Causes for 9, Alfa 2B, For, Inj, Interferon, MU

Show results in: 日本語

  • Interferon Alfa-n3

    The drug interferon alfa-2b is obtained by recombinant DNA technology from a strain of Escherichia coli bearing an interferon alfa-2b gene from human leukocytes.[] At the end of the follow-up period, 44% of patients in the 10 MU group maintained normal ALT, and 24% had nondetectable HCV RNA. Lower doses were much less effective.[] All 18 were evaluated twice, and 9 were evaluated three times. Analyses revealed few significant effects of treatment on cognitive, motor, and affective function.[] Interferon alpha binds less stably to type I interferon receptors than interferon beta.[] Monitor Closely Significant interaction possible (monitoring by your doctor required) interferon alfa-n3 inj and zidovudine oral interferon alfa-n3 inj increases levels of[] Seite 33 - Tyr- Ser- Met- Glu- His- Phe- Arg- Trp- Gly- Lys- Pro- Val- Gly- Lys- Lys- Arg- Arg- Pro- Val- Lys- Val- Tyr1 2 3 4 5 6 7 8 9 10 11 12 1.1 14 15 16 17 18 19 20[]

    Missing: For
  • Interferon Alfa-2b

    […] ζ, IFNK) Interferon omega (IFN-ω, IFNW1) Peginterferon alfa-2a Peginterferon alfa-2b Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors[] A week later, IFNalpha(2b) was initiated three times a week at a dose of 3 MU/m(2), which was escalated in increments of 3 MU/m(2).[] COMMON BRAND NAMES Intron A HOW SUPPLIED Intron A Intralesional Inj Pwd F/Sol: 10000000IU Intron A Intralesional Inj Sol: 0.5mL, 5000000IU Intron A Intramuscular Inj Pwd F[] METHODS: The study group comprised 32 HCV RNA-positive patients with HCV-related vasculitis: 20 patients were treated with rituximab and PEG-IFN alfa-2b (9 of whom had not[] LDI 3 MU three times a week was given for 24 months in arm B.[] The median follow-up time was 72·4 months (IQR 46·9-98·0).[]

    Missing: For
  • Mitomycin

    DISCUSSION: The treatment of these lesions is currently made with chemotherapy and immunotherapy agents, such as mitomycin-C, 5-fluorouracil, and interferon alfa 2B.[] A dual fluorescent and ultraviolet absorbent probe 4-methylumbelliferone (4-MU) was used as an internal standard (I.S.) for one-step detection of multiple drug analysis with[] Caspase-9 activation was assessed by verifying the cleaving of the caspase-9 49-kDa proform to the characteristic 35 kD fragment.[] PURPOSE: To compare the efficacy and safety of topical interferon alpha 2b (IFNα2b) and mitomycin C (MMC) for ocular surface squamous neoplasia.[] Adverse Reactions: Thrombocytopenia, leukopenia (cumulative myelosuppression); inj site reactions (eg, cellulitis), stomatitis, alopecia, renal toxicity, pulmonary toxicity[] […] promyelocytic leukemic (HL-60) cells: IC 50 0.05 µM (human); SMMC-7721 (Hepatocellular carcinoma cells): IC 50 2.44 µg/ml (Homo sapiens); P388 (Lymphoma cells): IC 50 0.01 µg/ml (Mus[]

    Missing: For
  • Interferon Alfa-2a

    What are interferon alfa-2a and interferon alfa-2b?[] Treatment with interferon alfa-2a, 3 MU 3 times/week for 4 weeks, and etretinate, 50 mg/day for 5 months, was initially successful, but lesions further relapsed 5 months after[] L [SD 3·95] vs 9·88   10(9)/L [6·63]; p 0·023). 14 (70%) of 20 patients in the treatment group had survived after 14 days, compared with seven (29%) of 24 in the comparator[] Interferon alpha binds less stably to type I interferon receptors than interferon beta.[] India - Alferon Vial, Inron-A Inj, Intalfa Vial, Lg Intermax Alpha Inj, Roferon-A Amp, Roferon-A Vial, Zavinex Inj. International - Roferon-A.[] Abstract A 66-year-old man was treated for chronic active hepatitis C with 3 MU of recombinant interferon alfa-2a three times weekly.[]

    Missing: For
  • Interferon Beta-1a

    Muir AJBornstein JDKillenberg PGAtlantic Coast Hepatitis Treatment Group, Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic[] Subjects were to receive by IM injection one 6 MU dose of AVONEX and one 6 MU dose of Rebif with doses administered 2 weeks apart.[] Fundam Clin Pharmacol. 2012 Apr;26(2):207-9. doi: 10.1111/j.1472-8206.2010.00914.x. Epub 2011 Feb 24.[] Interferon alfa 2b Interferon alfa n1 Interferon alfacon-1 Interferon alpha-n3 Interferon beta (IFN-β) ( IFNB1 , IFNB3 ) Interferon beta 1a Interferon beta 1b Interferon[] Give by SC inj at least 48hrs apart, preferably in the PM. Rotate inj site.[] The model considered 21 health states: EDSS 0-9 in RRMS, EDSS 0-9 in secondary-progressive multiple sclerosis (SPMS), and death.[]

    Missing: For
  • Dacarbazine

    -2b.[] -2) per day; days 1-5) or intravenous dacarbazine (800 mg m(-2); day 1), in combination with intravenous cisplatin (75 mg m(-2); day 1) and subcutaneous interleukin-2 (3 MU[] 9) versus 3·0 months (2·8-4·6), respectively.[] Treatment of metastatic malignant melanoma with recombinant interferon alpha-2. Immunobiology 1986;172:275–82. CrossRef Google Scholar 21.[] Adverse Reactions: Myelosuppression (eg, leukopenia, thrombocytopenia, anemia), anorexia, nausea, vomiting, flu-like syndrome, alopecia, facial flushing/paresthesia, inj site[] Mu, L., Feng, S.: Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel[]

    Missing: For
  • Pyomyositis

    If patients do not respond to above treatment, Inj. Vancomycin 500 mg IV 6 hourly. In children 10-15 mg/kg/dose every 6 hours IV.[] Muscle Nerve. 2015 Feb;51(2):293-6. doi: 10.1002/mus.24449. Epub 2014 Dec 23.[] Infect Dis Clin North Am 2005; 19:981–9 PubMed CrossRef Google Scholar 4. Drosos G. Pyomyositis, A literature review. Acta Orthop Belg 2005; 71:9–1.[] The patient was empirically treated for tuberculosis because positive enzyme-linked immunospot assay for interferon-γ of blood was reported at 2 days after aspiration of synovial[] Serological markers revealed a C-reactive protein of 221 mg/L and white cell count of 11.1 10 9 /L. A dry shoulder aspirate was obtained.[] Pharmacological Inj. Cloxacillin 500 mg IV 6 hourly for 5-10 days. In Children 12.5-25 mg/kg up to 500 mg IV 6 hourly. Following improvement, change to oral medication.[]

    Missing: Alfa 2B For
  • Interferon Alpha

    Interferon Alfa-2b Brand Names Interferon Alfa-2b may be found in some form under the following brand names: Intron A Interferon Alfa-2b Drug Class Interferon Alfa-2b is part[] A laboratory investigation revealed a thyroid stimulation hormone level of 0.005 mU/L (0.350-4.94), free thyroxine of 45.6 pmol/L (9.0-19.0) and free tri-iodothyronine of[] , Rose Y 1 , Neven B 13, 8, 9 , Hertel C 21 , Hayday A 22, 23 , Albert ML 2, 24, 3 , Rozenberg F 25 , Crow YJ 1, 13, 6, 26 , Duffy D 2, 24, 3 .[] Physicians should be alert to the possibility of interferon alpha-2a-related parkinsonism.[] COMMON BRAND NAMES Intron A HOW SUPPLIED Intron A Intralesional Inj Pwd F/Sol: 10000000IU Intron A Intralesional Inj Sol: 0.5mL, 5000000IU Intron A Intramuscular Inj Pwd F[] , Rt, Po, Bv, Eq Applications: WB, ICC/IF, IHC Species: Hu, Mu, Rt, Ca, Rb Applications: WB, Simple Western, ICC/IF, IHC, IHC-Fr, IHC-P Species: Hu, Mu, Rt, Ca, Eq, Mk, Pm[]

    Missing: For
  • Interleukin-2

    Treatment 1 uses interferon alfa-2b (IFN-A) therapy, and treatment 2 includes adjuvant biochemotherapy.[] Organism: Mus musculus , mouse / Tissue: thymus / Disease: lymphoma Organism Mus musculus , mouse Tissue thymus Product Format frozen Morphology lymphoblast Culture Properties[] J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.[] […] of interval) plus interferon-alpha (IFN-alpha) (3 MU s.c. t.i.w., also covering the intervals between IL-2 cycles) for a metastatic renal carcinoma.[] Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.[] Each HD IL-2 cycle was given over 5 days, cycles were repeated after 9 days and courses (2 cycles) were repeated every 6-9 weeks in patients with stable or responding disease[]

    Missing: For Inj
  • Psoralen

    -2b combination therapy.[] (Pall B) and hybridised to a radioactively labelled, singlestranded probe matching 2379–2539 MU.[] 9 0·5 and 4·0 0·6 by day 180.[] KEYWORDS: PUVA; cutaneous T-cell lymphoma; interferon; large-cell transformation; localized radiation; mycosis fungoides; phototherapy[] BACKGROUND: Photochemotherapy with psoralen and ultraviolet A (PUVA), with or without adjuvant interferon-α (IFN-α), is a first-line therapy for early-stage mycosis fungoides[] Total UVA doses received were 107 J cm(-2) (range 1·4-489·9) in the PUVA arm vs. 101·7 J cm(-2) (0·2-529·9) in the combination arm.[]

    Missing: For Inj

Similar symptoms